Abstract:OBJECTIVE: To reevaluate the bioequivalence of marked metformin hydrochloride enteric-coated tablets. METHODS: Using method 2 described in the appendix X D and apparatus 1 described in the appendix X C in Chinese Pharmacopoeia(edition 2010), the in vitro release of metformin hydrochloride enteric-coated tablets from different pharmaceutical factories (A, B, C, and D) was investigated. The contents were measured by utlraviolet (UV) spectroscopy. Generic tablets from factory A and D were chosen to be test 1 and test 2 preparations, with the innovative metformin hydrochloride tablets (Glucophage) as the reference preparation. In a randomized, three-way crossover study, 21 healthy male volunteers were given a single oral dose of test 1, test 2 and reference preparations containing 500 mg of metformin hydrochloride. Plasma concentrations of metformin were determined by LC-MS/MS. The pharmacokinetic parameters and relative bioavailability were calculated. The bioequivalence between test 1 and reference preparation, test 2 and reference preparation, and the bioequivalence between the two test preparations were evaluated. RESULTS: The in vitro release of metformin hydrochloride enteric-coated tablets from factory B, C and D met the standard of Chinese Pharmacopoeia(the supplement edition of 2010) while that of the tablets from factory A did not. Metformin hydrochloride enteric-coated tablets from factory A and D were chosen to be test 1 and test 2 preparations, respectively. The F 0-t and F 0-∞ were (72.8 ± 9.7)% and (73.2 ± 10.0)% for test 1 preparation, and (45.5 ± 16.2)% and (46.2 ± 16.0)% for test 2 preparation, respectively. It was failed to conclude that test 1 and reference preparation were bioinequivalent. Test 2 and reference preparation were bioinequivalent, and the two test preparations were also bioinequivalent. CONCLUSION: The bioinequivalence risk of metformin hydrochloride enteric-coated tablets is high. For metformin hydrochloride enteric-coated tablets, not only conducting pre-marketing bioequivalence study with proper reference preparation, but also enhancing post-marketing surveillance and reevaluation of bioequivalence are very important for maintaining the consistency of drugs quality. Copyright 2012 by the Chinese Pharmaceutical Association.

Discussion on the problems and strategies in bioequivalence tests of drug preparations

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Questions in the Bioequivalence Tests of the Preparations Containing Metformin Hydrochloride

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Opinions and suggestions of bioequivalent studies on modified new drugs

The Discussion on Several Key Questions in Human Bioequivalence Study of Oral Preparation of Terazosin Hydrochloride

Problems and Countermeasures in Domestic Human Bioequivalence Studies for the Oral Preparations Containing Omeprazole or Its Salt

Determining Equivalence for Generic Locally Acting Drug Products

Post-Marketing Reevaluation of Bioequivalénce of Metformin Hydrochloride Enteric-Coated Tablets

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Study on Bioequivalence of Ambroxol Hydrochloride Tablets from Domestic and Import

Bioequivalence Study of High Performance Liquid Chromatography Towards Cefetamet Pivoxil

The Discussion on strategy improving the safety in human bioequivalence study

Study on Bioequivalence of Risperidone Tablets

Bioequivalence evaluation of two formulations of pidotimod using a limited sampling strategy.

Pharmacokinetics and Bioequivalence Study of Cefixime Tablet in Healthy Volunteers

Update on the advances and challenges in bioequivalence testing methods for complex topical generic products

Pharmacokinetic And Bioequivalence Study Of Three Oral Formulations Of Ambroxol 30 Mg: A Randomized, Three-Period Crossover Comparison In Healthy Volunteers

In Vitro Bioequivalence Testing.

Bioequivalence of trimetazidine dihydrochloride tablets in Chinese healthy subjects